PDCD1 and neoplasm: PD-1+ NK cells may be inhibited in killing tumor cells instead of being anergic in PD-L1+ tumors, which means that PD-1 is an important checkpoint for NK activation and PD-1 blockade might elicit an antitumor NK cell response (102).